Article
CMTM4 as a new partner for IL-17 receptor: adding a piece in the puzzle of IL17-driven diseases
2023-05-05
Abstract excerpt
IL-17 has emerged as an important cytokine in protecting the host from mucosal infections, but also as a pathogenic determinant and therapeutic target in numerous autoimmune and inflammatory diseases (e.g. psoriasis, psoriatic arthritis and ankylosing spondylitis, inflammatory bowel disease and multiple sclerosis) [(1)](#ref-0001). The IL-17 family includes six members (IL-17A to IL-17F) that act through the IL-17...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e9e4194e-4712-521a-b9c9-3f8c2c3f4870
- DOI
- 10.22541/au.168325745.58960227/v1
